Search - tctmd.com

Displaying 81 - 100 of 1216

Sort: Relevancy | Date

News Daily News

DRIVE-STEMI Supports Less Restrictive Driving Guidance After Acute MI

L.A. McKeown

January 23, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

January 21, 2025

News Daily News

Athletes’ Hearts Also Require Careful Scrutiny, New Review Suggests

Yael L. Maxwell

January 17, 2025

News Daily News

Deferred Revascularization Safer When Guided by FFR vs QFR: FAVOR III Europe

Caitlin E. Cox

January 09, 2025

News Daily News

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Michael O'Riordan

January 03, 2025

News Daily News

Some Guidance for Managing Patients With AS and CAD: Review

Yael L. Maxwell

December 24, 2024

News Daily News

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Todd Neale

December 20, 2024

News Daily News

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

Todd Neale

December 06, 2024

News Daily News

EXCEL Data Highlight Bleeding Patterns After CABG, PCI for LM Disease

Yael L. Maxwell

December 05, 2024

News Daily News

CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy

Todd Neale

December 04, 2024

News Daily News

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

Yael L. Maxwell

November 27, 2024

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

News Conference News AHA 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Michael O'Riordan

November 17, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2024

Shelley Wood

November 01, 2024

Presentation TCT 2024

TCT 346: Assessment of Long-Term Clinical Outcomes of De Novo DCB Performance: Patient Data Meta-Analysis of Randomized Clinical Trials: Final Results of the ANDROMEDA Study

Presenter: Bernardo Cortese

October 30, 2024

Presentation TCT 2024

The TARGET-IV Trial: International Multicenter Randomized Assessment of the Firehawk® Rapamycin Eluting Coronary Stent System

Presenter: Olivier Bertrand

October 30, 2024

Presentation TCT 2024

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

Presenter: Hongbo Yang

October 30, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

Advertisement

DRIVE-STEMI Supports Less Restrictive Driving Guidance After Acute MI

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

Athletes’ Hearts Also Require Careful Scrutiny, New Review Suggests

Deferred Revascularization Safer When Guided by FFR vs QFR: FAVOR III Europe

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Some Guidance for Managing Patients With AS and CAD: Review

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

EXCEL Data Highlight Bleeding Patterns After CABG, PCI for LM Disease

CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

TCTMD’s Top 10 Most Popular Stories for October 2024

TCT 346: Assessment of Long-Term Clinical Outcomes of De Novo DCB Performance: Patient Data Meta-Analysis of Randomized Clinical Trials: Final Results of the ANDROMEDA Study

The TARGET-IV Trial: International Multicenter Randomized Assessment of the Firehawk® Rapamycin Eluting Coronary Stent System

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content